The IPI Model: Breaking Down CMS’s Proposed Drug Pricing Model

Overview


Join McDermott for a Webinar on Changes to the Pharma Ecosystem

The Centers for Medicare and Medicaid Services (CMS)’s October 25 announcement of an Advanced Notice of Proposed Rulemaking with Comment proposes to implement an international pricing index model for Medicare Part B drugs and biologicals. This model has the potential to make sweeping changes to the entire pharmaceutical ecosystem.

Join McDermott Will & Emery’s Emily Cook and McDermott+Consulting’s John Warren as they lead a discussion on the impact of CMS’s proposed model and break down the implications on stakeholder groups from providers to drug manufacturers.

Click here to register.

For more information, please contact Jennifer Randles.

Dig Deeper

New York, NY / Speaking Engagements / January 27-31, 2020

2020 NYSBA Annual Meeting

New York, NY / Speaking Engagements / December 8-9, 2019

2019 ACI Drug and Medical Device Litigation Conference

Paris, France / McDermott Event / November 29, 2019

FDA Regulatory Regime | Trends and Developments

Düsseldorf, Germany / McDermott Event / November 20, 2019

US Market Entry Forum and Networking Reception During MEDICA

Webinar / McDermott Event / November and December 2019

Regulatory Sprint to Coordinate Care Webinars